Anara —Anara helps research teams find, understand, organize and write scientific documents, together.

We stumbled across Anara while diving into the AI research tools space, and honestly, it caught our attention for all the right reasons. This isn't just another "AI summarizes papers" tool — it's a thoughtfully designed research assistant that seems to actually understand how researchers work.

What impressed us most is the journey from Unriddle to Anara. Founder Naveed spent 18 months building something for general comprehension, then made the smart pivot to focus specifically on researchers. That kind of focused iteration usually leads to better products, and it shows here.

The Citation Game-Changer

Here's where Anara really shines: their citation system is bulletproof. Every summary comes with clickable citations that link directly back to the original source. No hallucinations, no made-up references — just solid, traceable information.

We've seen too many AI tools confidently cite papers that don't exist. Anara's approach feels like they actually understand the stakes of research integrity, which is refreshing in a space full of flashy but unreliable tools.

Built for Real Workflows

The conversational QA interface caught our eye because it feels natural. You can literally chat with your research library like you're talking to a knowledgeable colleague. Want to compare findings across multiple papers? Just ask. Need to understand a complex methodology? The AI walks you through it.

The fact that it handles 90+ languages is a nice touch too — research is global, and Anara seems to get that. Plus, the team collaboration features suggest they're thinking beyond individual researchers to entire lab groups and companies.

The Numbers Tell a Story

Here's what really validates Anara: they've hit 3 million users and $2.5M in ARR in just 18 months. That's not just hype — that's researchers actually paying for and using the tool daily. The fact that they're backed by GitHub and Reddit founders adds credibility, but the user growth speaks louder.

We're particularly intrigued by their expansion beyond academia into biotech and R&D teams. That suggests the platform is robust enough for commercial research environments, which is a high bar to clear.